Track: Neurological Outcomes After Effect of COVID- 19

Neurological Outcomes After Effect of COVID- 19

As the world still struggles to deal with the COVID-19 pandemic's effects, emerging evidence highlights significant neurological consequences that are affecting millions. The Neurological Outcomes After Effect of COVID-19 session will explore the wide range of neurological consequences associated with COVID-19, shedding light on how the virus has impacted the nervous system and what this means for long-term health.

Impact of COVID-19 on Neurological Health: This session will delve into how COVID-19 has been linked to a range of neurological issues, including cognitive impairment, headaches, anosmia (loss of smell), and more severe conditions such as stroke and encephalitis. Attendees will gain insights into the mechanisms through which SARS-CoV-2 affects the nervous system, including potential direct viral invasion and indirect effects through inflammatory responses.

Long-term Neurological Result of COVID-19: This segment will focus on long-term neurological sequelae observed in post-COVID patients. Attendees will examine studies and data on persistent symptoms such as brain fog, memory issues, and other cognitive deficits. The discussion will also cover the prevalence of these conditions, their impact on quality of life, and the challenges faced in managing these persistent symptoms.

Case Studies and Clinical Findings: Interactive case studies will be presented to illustrate real-world examples of neurological outcomes in COVID-19 patients. This section will encourage participants to engage with the data through case discussions and analysis, fostering a deeper understanding of the complexities involved in diagnosing and treating neurological complications.

Advances in Diagnosis and Treatment: Recent advancements in the diagnosis and treatment of COVID-19-related neurological issues will be highlighted. This session will include innovative diagnostic tools, emerging treatment protocols, and multidisciplinary approaches to managing neurological symptoms. Participants will have the opportunity to explore new research and discuss the implications for clinical practice.

Future Research Directions: Finally, This session will discuss the ongoing research and future directions needed to address the neurological impact of COVID-19. This will include identifying gaps in current knowledge, potential areas for further investigation, and the role of international collaboration in advancing our understanding and response to these neurological challenges.